Recent advances in understanding and managing hairy cell leukemia

F1000Research
Tobias RoiderSascha Dietrich

Abstract

Hairy cell leukemia is a rare B-cell malignancy that is characterized by an indolent course. It was initially described as a distinct entity in 1958. Before the establishment of modern treatment, median survival was only 4 years. Since then, major advances in the treatment and understanding of the biology and genomic landscape of hairy cell leukemia have been made. This review summarizes the present understanding of hairy cell leukemia with particular focus on the development of novel and targeted approaches to treatment.

References

Apr 19, 1990·The New England Journal of Medicine·L D PiroE Beutler
Apr 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M GreverH Golomb
Mar 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A HoffmanK R Rai
Aug 5, 2005·Nature·Chrysiis MichaloglouDaniel S Peeper
May 26, 2006·Nature Reviews. Cancer·Enrico TiacciBrunangelo Falini
Mar 21, 2008·Nature Reviews. Cancer·Isabel M ChuJoyce M Slingerland
Jun 19, 2010·Cancer Treatment Reviews·Tadeusz Robak
Sep 8, 2010·The New England Journal of Medicine·Keith T FlahertyPaul B Chapman
May 25, 2011·Nature Reviews. Clinical Oncology·Antoni Ribas, Keith T Flaherty
Jun 15, 2011·The New England Journal of Medicine·Enrico TiacciBrunangelo Falini
Apr 26, 2012·The American Journal of Surgical Pathology·Mindaugas AndrulisDavid Capper
May 25, 2012·The New England Journal of Medicine·Sascha DietrichThorsten Zenz
Jan 3, 2013·British Journal of Haematology·George A FollowsMike A Scott
May 22, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sascha DietrichThorsten Zenz
Jun 5, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Javier MunozRazelle Kurzrock
Sep 17, 2013·Cytometry. Part B, Clinical Cytometry·Alex F SandesEdgar G Rizzatti
Nov 19, 2013·Nature Genetics·Joshua J WaterfallPaul S Meltzer
Jan 17, 2014·The New England Journal of Medicine·Jesvin SamuelMartin J S Dyer
Jan 18, 2014·British Journal of Haematology·Sebastian TschernitzEva Geissinger
Apr 23, 2014·British Journal of Haematology·Edouard CornetUNKNOWN Société Française d'Hématologie
May 30, 2014·Science Translational Medicine·Stephen S ChungOmar Abdel-Wahab
Dec 17, 2014·American Journal of Clinical Pathology·Guldeep UppalJerald Z Gong
Mar 31, 2015·Oncoscience·Caroline BailleuxFrederic Peyrade
Jun 13, 2015·Blood·Sascha DietrichThorsten Zenz
Aug 14, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T RobakUNKNOWN ESMO Guidelines Committee
Sep 10, 2015·The New England Journal of Medicine·Enrico TiacciMartin S Tallman
Nov 29, 2015·Best Practice & Research. Clinical Haematology·Tamar Tadmor, Aaron Polliack
Nov 29, 2015·Best Practice & Research. Clinical Haematology·Monica ElseDaniel Catovsky
Jan 12, 2016·Therapeutic Advances in Medical Oncology·Zeynep Eroglu, Antoni Ribas
Mar 5, 2016·Blood·Sascha DietrichThorsten Zenz
Aug 25, 2016·Blood·Brunangelo FaliniEnrico Tiacci
Sep 13, 2016·CA: a Cancer Journal for Clinicians·Lauren R TerasChristopher R Flowers

❮ Previous
Next ❯

Methods Mentioned

BETA
bone marrow aspiration
flow
biopsies

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Related Papers

Der Internist
Sascha DietrichThorsten Zenz
Revista clínica española
A Sánchez Rodríguez, A Jiménez López
© 2022 Meta ULC. All rights reserved